AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway

Hepatocellular carcinoma (HCC) is one of the most frequent and aggressive malignant neoplasms, and is associated with a poor prognosis. Therefore, there is a crucial need to develop novel cancer therapies and identify novel therapeutic targets. Aldo-keto reductase family 1 member B10 (AKR1B10) is ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Ke, Deng, Ying, Li, Zhipeng, Zhou, Huaxin, Yao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688483/
https://www.ncbi.nlm.nih.gov/pubmed/38034486
http://dx.doi.org/10.3892/ol.2023.14151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688483/
https://www.ncbi.nlm.nih.gov/pubmed/38034486
http://dx.doi.org/10.3892/ol.2023.14151

Ejemplares similares